Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).

被引：2
作者：
Ghatalia, Pooja
Handorf, Elizabeth A.
Deng, Mengying
Zibelman, Matthew R.
Abbosh, Philip
Anari, Fern
Greenberg, Richard E.
Viterbo, Rosalia
Chen, David
Smaldone, Marc C.
Kutikov, Alexander
Geynisman, Daniel M.
Uzzo, Robert Guy
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] FCCC, Philadelphia, PA USA
[3] Fox Chase Canc Ctr, Dept Hematol & Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4582
引用
收藏
页数：3
相关论文
共 50 条
  • [41] IS THERE A ROLE FOR NEPHRON SPARING CYTOREDUCTIVE PARTIAL NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA?
    Hockman, Lukas
    McGuffey, Logan
    Dwan, Aaron
    Pokala, Naveen
    JOURNAL OF UROLOGY, 2018, 199 (04) : E782 - E782
  • [42] Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
    Braun, Avery E.
    Meng, Maxwell, V
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (07): : 1002 - 1004
  • [43] Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology
    Alhalabi, Omar
    Karam, Jose A.
    Tannir, Nizar M.
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 521 - 525
  • [44] Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)
    Gunenc, Damla
    Issa, Wadih
    Gerald, Thomas
    Zhou, Qinhan
    Zhang, Song
    Ibezue, I. Chidera
    Bhanvadia, Raj
    Tachibana, Isamu
    Brugarolas, James
    Hammers, Hans
    Qin, Qian
    Kapur, Payal
    Woldu, Solomon
    Gaston, Kris
    Lotan, Yair
    Cadeddu, Jeffrey
    Wang, Andrew Z.
    Margulis, Vitaly
    Zhang, Tian
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [45] Refining the Use of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
    La Rochelle, Jeffrey
    Wood, Christopher
    Bex, Axel
    SEMINARS IN ONCOLOGY, 2013, 40 (04) : 429 - 435
  • [46] The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
    Studentova, Hana
    Spisarova, Martina
    Kopova, Andrea
    Zemankova, Anezka
    Melichar, Bohuslav
    Student, Vladimir
    CANCERS, 2023, 15 (15)
  • [47] The Case for Cytoreductive Nephrectomy for the Management of Metastatic Renal Cell Carcinoma
    Carver, Brett S.
    JOURNAL OF UROLOGY, 2009, 182 (03) : 833 - 834
  • [48] Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma
    Harshman, Lauren C.
    Srinivas, Sandy
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1749 - 1761
  • [49] Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma
    Beisland, Christian
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (06) : 500 - 500
  • [50] Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
    Mejean, Arnaud
    Ravaud, Alain
    Thezenas, Simon
    Chevreau, Christine
    Bensalah, Karim
    Geoffrois, Lionnel
    Thiery-Vuillemin, Antoine
    Cormier, Luc
    Lang, Herve
    Guy, Laurent
    Gravis, Gwenaelle
    Rolland, Frederic
    Linassier, Claude
    Lechevallier, Eric
    Oudard, Stephane
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Bernhard, Jean Christophe
    Colas, Sandra
    Albiges, Laurence
    Lebret, Thierry
    Treluyer, Jean-Marc
    Timsit, Marc-Olivier
    Escudier, Bernard
    EUROPEAN UROLOGY, 2021, 80 (04) : 417 - 424
12345